Depression disorder and

The authors concluded that antidepressants exert a modest beneficial effect for patients with combined depressive disorder and substance use disorder. They also emphasized that antidepressants are not a stand-alone treatment for depressed alcoholic patients and that concurrent therapy directly targeting the substance use disorder is also indicated. 

For more information on the side effects, pharmacokinetics, and drug interactions of specific agents, refer to Chap. 71 on Schizophrenia, Chap. 70 on Major Depressive Disorder, and Chap. 52 on Epilepsy. 

The mood disorders were once called affective disorders and are grouped into two main categories unipolar and bipolar. The unipolar depressive disorders include major depressive disorder and dysthymic disorder the bipolar disorders include bipolar 1, bipolar II, bipolar not otherwise specified, and cyclothymic disorder. Other mood disorders are substance-induced mood disorders and mood disorders due to a general medical condition. In addition, mood disturbance commonly occurs as a symptom in other psychiatric disorders including dementia, post-traumatic stress disorder, substance abuse disorders, and schizophrenia. 

Amoxapine Relief of depressive symptoms in patients with neurotic or reactive depressive disorders and endogenous and psychotic depression depression accompanied by anxiety or agitation. 

Primary care physicians were recruited in four physician networks by mail with telephone follow-up, and were told only that the study would involve seeing two standardized patients several months apart, that each patient would present with a combination of common symptoms, and that the purpose of the study was to assess social influences on practice and the competing demands of primary care. The physician visits were surreptitiously audiotaped. Eighteen standardized patients completed a total of 149 encounters presenting with major depressive disorder, and another 149 with adjustment disorder, with each split approximately evenly among the three patient request types. 

In sum, the experimental evidence leads one to the conclusion that both undertreatment of depression (in the case of those presenting with major depressive disorder) and overtreatment with antidepressants (for those... 

Substantial evidence suggests a deficiency of DA in depressive disorders and the involvement of mesolimbic dopaminergic mechanisms in antidepressant... 

Psychiatr Chn North Am 19 179-200, 1996 Fava M, Rosenbaum JF, McGrath PJ, et al Dthium and tricyclic augmentation of fluoxetine treatment for resistant major depression a double-blind, controlled study. Am J Psychiatry 151 1372-1374, 1994 Fawcett J Suicide risk factors in depressive disorders and panic disorder. J Clin Psychiatry 53 [suppl 3) 9-13, 1992... 

Targnm, S.D. Differential responses to anxiogenic challenge studies in patients with major depressive disorder and panic disorder. Biol. Psvchiatrv 28, 21-34, 1990. 

Antidepressants for minor and major depressive disorders and mood stabilisers (anfimanic drugs) for mania. 

Preventing relapse is of critical importance in the life course of major depressive disorder, and every effort should be made to ensure patient compliance. 

Schleifer SJ, Keller SE, Bond RN, et al. Major depressive disorder and immunity role of age, sex, severity and hospitalization. Arch Gen Psychiatry 1989 46 81-87. 

Fawcett J. Suicide risk factors in depressive disorders and in panic disorder. J din Psychiatry 1992 5[3, Suppl] 9-13. 

Original drug classifications in the 1960s emphasized that there were important distinctions between the antidepressants (e.g., tricyclic antidepressants) versus the anxiolytics (e.g., benzodiazepines) available at that time. This reflected the diagnostic notions then prevalent, which tended to dichotomize major depressive disorder and... 

Bauer M, Whybrow PC, Angst J, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 2 Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold depressions. World J Biol Psychiatry. 2002 3 69-86. 

Methylphenidate also has been used to treat other medical conditions. For example, it has been used as a short-term treatment for depression in the medically ill, as an adjunct to conventional antidepressants for patients with major depressive disorder, and in combination with opiates for pain control. Methylphenidate has been prescribed to reduce apathy in patients with dementia or other brain diseases (28,34,35). 

Several studies have discussed the relationship between serum cholesterol and suicide, violence, anxiety disorders, depressive disorders, and schizophrenia [1-3]. Some of these papers suggested that low or lowering cholesterol levels could cause or worsen depressive symptoms and increase the risks of suicide and violence death. There are many reports that discussed the relationships between the lipid profiles, depression, and suicide from the viewpoints of decreased serotonergic transmission on suicide behavior [4, 5], lower serum cholesterol and serotonin levels [6, 7], serum cholesterol levels and polymorphism in the promoter region of the serotonin transporter gene for depression and suicide [8-10], low serum cholesterol and suicide risk [11, 12], and serotonergic receptor function [13, 14]. These studies supported the hypothesis that reduced cholesterol levels resulted in reduced central serotonin transmission. 

In clinical practice, depressive symptoms were common in patients with physical illness, including cardiovascular disease, diabetes mellitus, end-stage renal disease, and women in pregnancy, following delivery or menopause. However, data that specifically addressed serum lipid profiles in patients with depressive disorders and physical illnesses were still scarce. 

Depressive Disorders and Lipid Profile Levels in Psychiatric Inpatients... 

In Taiwan, Huang et al. investigated the correlation between serum lipid, lipoprotein concentrations and major depressive disorder in patients admitted for general health screening [33]. They found that the ratios of TC/HDL and LDL/HDL showed significant differences between patients with major depressive disorder and normal controls in women. Huang and Chen also pointed out that no significant differences were found in lipid concentrations of TC, TG, HDL, VLDL, LDL, TC/HDL, and LDL/HDL between patients with dysthymia and normal controls [41],... 

In clinical studies, major depressive disorder has had four specifiers, including melancholic feature, atypical feature, catatonic feature, and postpartum onset. In the future, we should investigate the distributions of the four specifiers of depression among patients with physical illness and discuss which biological markers could link the depressive disorder and the physical illness. 

---